Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Overnight success proves elusive for oral MS drugs
Fierce Pharma
Tuesday, November 20, 2012 - 1:25pm
tags:
multiple sclerosis, MS, Novartis, Gilenya, Sanofi, Aubagio
A Fact Based Analysis Of Galena's NeuVax
Seeking Alpha
Tuesday, November 20, 2012 - 1:18pm
tags:
Galena Biopharma, NeuVax
Several Biopharmas That Look Ready For Upside Gains
Yahoo/Reuters
Tuesday, November 20, 2012 - 1:18pm
tags:
Sarepta, BG Medicine, Amicus, Santarus, Celldex
PDL BioPharma, AxoGen Benefit From 'Royal' Agreement
Seeking Alpha
Tuesday, November 20, 2012 - 1:16pm
tags:
PDL Biopharma, AxoGen
SEC alleges largest-ever insider-trading scheme
Marketwatch
Tuesday, November 20, 2012 - 1:13pm
tags:
SEC, insider trading, Elan, Pfizer, Wyeth
Nestle Purchase of Pfizer Unit Blocked in Mexico
Bloomberg
Tuesday, November 20, 2012 - 1:12pm
tags:
Nestle, Pfizer, Mexico, M&A, infant nutrition
Aeterna Zentaris: Late-Stage Drug Candidates Could Send Stock Higher
Seeking Alpha
Tuesday, November 20, 2012 - 11:36am
tags:
Aeterna Zentaris, AEZS-108, perifosine, AEZS-130
Sarepta Ready To Move Higher
Seeking Alpha
Tuesday, November 20, 2012 - 11:35am
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Alexza Pharma: Run-Up Trade Into December's Approval Decisions
TheStreet.com
Tuesday, November 20, 2012 - 11:32am
tags:
Alexza, FDA, Adasuve, antipsychotics
Testosterone, Viagra not a winning ED combination
Reuters
Tuesday, November 20, 2012 - 11:31am
tags:
Pfizer, erectile dysfunction, testosterone, Viagra
Takeda Consultant Loses Two Whistleblower Suits
Pharmalot
Tuesday, November 20, 2012 - 11:29am
tags:
Takeda, whistleblower lawsuits
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tuesday, November 20, 2012 - 11:27am
tags:
diabetes, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi
FDA Approval Victory a Yawner?
Motley Fool
Tuesday, November 20, 2012 - 11:24am
tags:
FDA, GSK, Ligand, Promacta, hepatitis C
Reckitt set to win Schiff as Bayer quits $1.4 bln fight
Reuters
Tuesday, November 20, 2012 - 11:22am
tags:
Schiff, Bayer AG, M&A, Reckitt Benckiser
The 3 Biggest Risks Facing GlaxoSmithKline
Motley Fool
Tuesday, November 20, 2012 - 11:21am
tags:
GSK
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Monday, November 19, 2012 - 2:00pm
tags:
Oncothyreon, Celsion, Arena Pharmaceuticals, NuPathe, Hemispherx, Amarin, Biogen Idec, Gilead, Hyperion Therapeutics, Celgene, Raptor Pharmaceuticals, Dynavax, Zogenix, Impax Labs
Illumina reveals bid for Complete Genomics
Markewatch
Monday, November 19, 2012 - 1:57pm
tags:
M&A, Illumina, Complete Genomics
Celgene's Lazorchak, Five Others, Charged With Insider Trading
Yahoo/Bloomberg
Monday, November 19, 2012 - 1:55pm
tags:
insider trading, Celgene
3 Things to Watch With Nektar Therapeutics
Motley Fool
Monday, November 19, 2012 - 1:55pm
tags:
Nektar, Naloxegol, AstraZeneca
Is This Biotech Fishing for a Higher Bid?
Motley Fool
Monday, November 19, 2012 - 1:26pm
tags:
Geron, BioTime, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.